Article

Practitioner acceptance grows for retinal exam

Marlborough, MA-Optos Inc. said its practitioner acceptance rate is growing for optomap plus Medical Retinal Exam, a procedure for medically necessary disease management and follow-up.

Marlborough, MA-Optos Inc. said its practitioner acceptance rate is growing for optomap plus Medical Retinal Exam, a procedure for medically necessary disease management and follow-up.

Practitioners use the core optomap Retinal Exam for wellness screening of patients presenting for comprehensive eye exams. optomap plus Medical Retinal Exam is used for patients that either have complaints that indicate pathology, have signs or symptoms of pathology, or have a medical history of pathology.

"The optomap plus Medical Retinal Exam allows a physician to turn the laser to look more specifically at the posterior pole or at the periphery when there is an area of concern, and provides irreplaceable information for following patients over time. The ability to measure a lesion actually in pixels is significant in terms of making sure our patients have excellent outcomes," said Richard Noyes, OD, of Iowa Eye Care.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.